Frosh v. Association for Accessible Medicines

Petition for certiorari denied on February 19, 2019
Docket No. Op. Below Argument Opinion Vote Author Term
18-546 4th Cir. N/A N/A N/A N/A OT 2018

Issue: Whether the commerce clause prohibits a state from protecting consumer access to essential off-patent and generic prescription drugs by requiring manufacturers to refrain from unconscionably raising the price of those drugs sold in the state.

SCOTUSblog Coverage

DateProceedings and Orders (key to color coding)
Oct 19 2018Petition for a writ of certiorari filed. (Response due November 26, 2018)
Nov 01 2018Blanket Consent filed by Petitioners, Brian Frosh, et al.
Nov 05 2018Waiver of right of respondent Association for Accessible Medicines to respond filed.
Nov 05 2018Blanket Consent filed by Respondents, Association for Accessible Medicines.
Nov 07 2018DISTRIBUTED for Conference of 11/30/2018.
Nov 13 2018Response Requested. (Due December 13, 2018)
Nov 15 2018Motion to extend the time to file a response from December 13, 2018 to January 14, 2019, submitted to The Clerk.
Nov 16 2018Motion to extend the time to file a response is granted and the time is extended to and including January 14, 2019.
Nov 21 2018Brief amici curiae of Gerard F. Anderson; Joshua M. Sharfstein filed.
Dec 13 2018Brief amici curiae of Legal Scholars filed.
Dec 13 2018Brief amici curiae of National Health Law Program, et al. filed.
Jan 14 2019Brief of respondent Association for Accessible Medicines in opposition filed.
Jan 25 2019Reply of petitioners Brian Frosh, et al. filed.
Jan 30 2019DISTRIBUTED for Conference of 2/15/2019.
Feb 19 2019Petition DENIED.
 
Share:
Term Snapshot
Awards